Involvement of adrenoceptors, dopamine receptors and AMPA receptors in antidepressant-like action of 7-O-ethylfangchinoline in mice

Involvement of adrenoceptors, dopamine receptors and AMPA receptors in antidepressant-like action of 7-O-ethylfangchinoline in mice
复制标题

DOI:
10.1038/aps.2015.57
复制
发表时间:
2015-08
期刊:
--
影响因子:
--
通讯作者:
Zhao-fu Sheng;Xiang-yu Cui;S. Cui;B. Yu;Xue-qiong Zhang;Sheng-jie Li;Qing Cao;Yuan-li Huang;Ya-ping Xu;Jin-zhi Song;Hui Ding;Zhi-ge Lin;Guang Yang;Yong-He Zhang
Zhao-fu Sheng;Xiang-yu Cui;S. Cui;B. Yu;Xue-qiong Zhang;Sheng-jie Li;Qing Cao;Yuan-li Huang;Ya-ping Xu;Jin-zhi Song;Hui Ding;Zhi-ge Lin;Guang Yang;Yong-He Zhang
中科院分区:
其他
文献类型:
--
作者:
Zhao-fu Sheng;Xiang-yu Cui;S. Cui;B. Yu;Xue-qiong Zhang;Sheng-jie Li;Qing Cao;Yuan-li Huang;Ya-ping Xu;Jin-zhi Song;Hui Ding;Zhi-ge Lin;Guang Yang;Yong-He Zhang

文献摘要

相似文献

目的:7-O-乙基防己诺林(YH-200)是一种双苄基异喹啉衍生物。方法:在小鼠强迫游泳实验(FST)、悬尾实验(TST)和旷场实验(OFT)前,ig YH-200(15、30和60 mg/kg)或tetrandrine(30和60 mg/kg)。YH-200(60 mg/kg)对FST的作用强于天然双苄基异喹啉生物碱粉防己碱(60 mg/kg)。预先给予α 1受体拮抗剂哌唑嗪(1 mg/kg)、β受体拮抗剂普萘洛尔(2 mg/kg)、多巴胺D1/D5受体拮抗剂SCH 23390(0.05mg/kg)、多巴胺D2/D3受体拮抗剂氟哌啶醇(0.2mg/kg)或AMPA受体拮抗剂NBQX(10 mg/kg)可阻断YH-200(60 mg/kg)的抗抑郁作用。与此相反,预先给予α 2肾上腺素受体拮抗剂育亨宾(1 mg/kg)可增强YH-200(30 mg/kg)的抗抑郁作用。慢性给药YH-200(30和60 mg/kg,14天)没有产生耐药性,相反,其抗抑郁样作用得到加强。结论:YH-2 0 0对小鼠的抗抑郁作用是通过作用于α 1、α 2、β肾上腺素受体、D1/D5、D2/D3受体以及AMPA受体等多靶点发挥的
Aim:7-O-ethylfangchinoline (YH-200) is a bisbenzylisoquinoline derivative. The aim of this study was to investigate the antidepressant-like action and underlying mechanisms of YH-200 in mice.Methods:Mice were treated with YH-200 (15, 30, and 60 mg/kg, ig) or tetrandrine (30 and 60 mg/kg, ig) before conducting forced swimming test (FST), tail suspension test (TST), or open field test (OFT).Results:YH-200 (60 mg/kg) significantly decreased the immobility time in both FST and TST, and prolonged the latency to immobility in FST. YH-200 (60 mg/kg) was more potent than the natural bisbenzylisoquinoline alkaloid tetrandrine (60 mg/kg) in FST. Pretreatment with α 1-adrenoceptor antagonist prazosin (1 mg/kg), β-adrenoceptor antagonist propranolol (2 mg/kg), dopamine D 1/D 5 receptor antagonist SCH23390 (0.05 mg/kg), dopamine D 2/D 3 receptor antagonist haloperidol (0.2 mg/kg) or AMPA receptor antagonist NBQX (10 mg/kg) prevented the antidepressant-like action of YH-200 (60 mg/kg) in FST. In contrast, pretreatment with α 2 adrenoceptor antagonist yohimbine (1 mg/kg) augmented the antidepressant-like action of YH-200 (30 mg/kg) in FST. Chronic administration of YH-200 (30 and 60 mg/kg for 14 d) did not produce drug tolerance; instead its antidepressant-like action was strengthened. Chronic administration of YH-200 did not affect the body weight of mice compared to control mice.Conclusion:YH-200 exerts its antidepressant-like action in mice via acting at multi-targets, including α 1, α 2 and β-adrenoceptors, D 1/D 5 and D 2/D 3 receptors, as well as AMPA receptors.